We are live on ! Find out more
Natixis Advisors

Natixis Advisors Portfolio holdings

AUM $71.9B
1-Year Est. Return 28.03%
This Fund
S&P 500
This Quarter Est. Return
+4.71%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$9.24B
AUM Growth
+$214M
Cap. Flow
-$121M
Cap. Flow %
-1.31%
Top 10 Hldgs %
14.66%
Holding
1,099
New
67
Increased
506
Reduced
447
Closed
79

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$18.6M
2
JPM icon
JPMorgan Chase
JPM
+$15.8M
3
EVHC
Envision Healthcare Holdings Inc
EVHC
+$15.6M
4
TSM icon
TSMC
TSM
+$15.4M
5
HAS icon
Hasbro
HAS
+$13.4M

Sector Composition

Rank Sector Weight
1 Financials 16.07%
2 Technology 14.26%
3 Healthcare 12.43%
4 Consumer Discretionary 10.12%
5 Industrials 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCI icon
76
Johnson Controls International
JCI
$87.1B
$23.5M 0.25%
540,965
+59,736
+12% +$2.5M
ADP icon
77
Automatic Data Processing
ADP
$98B
$23.4M 0.25%
228,145
+10,707
+5% +$1.08M
WBA
78
DELISTED
Walgreens Boots Alliance
WBA
$23.2M 0.25%
295,807
-99,664
-25% -$8.2M
VZ icon
79
Verizon
VZ
$188B
$23.1M 0.25%
517,789
+87,172
+20% +$4.06M
BIV icon
80
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$23M 0.25%
272,247
+3,705
+1% +$313K
UN
81
DELISTED
Unilever NV New York Registry Shares
UN
$22.9M 0.25%
414,056
+16,217
+4% +$876K
ABT icon
82
Abbott
ABT
$178B
$22.1M 0.24%
455,486
+22,948
+5% +$1.04M
AVGO icon
83
Broadcom
AVGO
$1.83T
$21.9M 0.24%
941,540
-231,460
-20% -$5.37M
ELV icon
84
Elevance Health
ELV
$82B
$21.7M 0.24%
115,559
-46,917
-29% -$8.43M
THO icon
85
Thor Industries
THO
$3.91B
$21.5M 0.23%
205,999
-1,402
-0.7% -$136K
GSK icon
86
GSK
GSK
$103B
$21.2M 0.23%
392,406
-4,241
-1% -$226K
VOE icon
87
Vanguard Mid-Cap Value ETF
VOE
$23.6B
$20.8M 0.23%
202,122
+43,719
+28% +$4.47M
ADI icon
88
Analog Devices
ADI
$184B
$20.7M 0.22%
266,444
+12,977
+5% +$1.03M
TXN icon
89
Texas Instruments
TXN
$257B
$20.6M 0.22%
267,653
-32,900
-11% -$2.64M
STI
90
DELISTED
SunTrust Banks, Inc.
STI
$20.5M 0.22%
361,250
+22,741
+7% +$1.26M
RDS.A
91
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$20.4M 0.22%
383,907
+50,081
+15% +$2.68M
MMM icon
92
3M
MMM
$87.9B
$20.2M 0.22%
116,276
-11,641
-9% -$1.95M
MET icon
93
MetLife
MET
$59.5B
$20.2M 0.22%
413,308
+21,405
+5% +$993K
XOM icon
94
ExxonMobil
XOM
$652B
$20.2M 0.22%
249,959
+7,243
+3% +$593K
EL icon
95
Estee Lauder
EL
$29B
$19.8M 0.21%
206,140
+121,360
+143% +$11.1M
TFCF
96
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$19.6M 0.21%
703,105
+216,460
+44% +$6.14M
WELL icon
97
Welltower
WELL
$176B
$19.6M 0.21%
261,572
-5,303
-2% -$388K
ITW icon
98
Illinois Tool Works
ITW
$80.3B
$19.5M 0.21%
136,371
-15,565
-10% -$2.17M
DEO icon
99
Diageo
DEO
$45.8B
$19.5M 0.21%
162,470
+4,003
+3% +$477K
PPG icon
100
PPG Industries
PPG
$25.6B
$19.3M 0.21%
175,075
+3,988
+2% +$431K

Similar funds

Natixis Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Natixis Advisors held 1,099 positions worth $9.24B, up 2.4% from $9.03B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Natixis Advisors's Q2 2017 filing shows 67 new, 506 increased, 447 reduced and 79 closed positions. Its largest new stake was Sherwin-Williams: 113,283 shares worth $13.3M. The largest sale was Honeywell, an estimated $18.6M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Natixis Advisors's largest Q2 2017 buy was Sherwin-Williams: 113,283 shares worth $13.3M.
  • Natixis Advisors added most to Nuance Communications, Inc. in Q2 2017, an estimated $15.1M increase.
  • Natixis Advisors's biggest Q2 2017 reduction was Honeywell, cutting an estimated $18.6M.
  • Natixis Advisors fully exited WESCO International in Q2 2017, selling an estimated $6.33M.
  • Natixis Advisors's ten largest holdings make up 15% of its $9.24B portfolio in Q2 2017.
  • Natixis Advisors opened 67 new positions and closed 79 in Q2 2017.
  • Natixis Advisors's portfolio value rose 2.4% quarter-over-quarter to $9.24B.

Based on Natixis Advisors's 13F filing for Q2 2017, filed 27 Jul 2017.